Company / Financials
Xenetic Biosciences, Inc. Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$2.5M
FY2025 · -1.6% YoY
Net Income
-$4.0M
FY2025 · +4.2% YoY
Profit Margin
-158.4%
FY2025 · net income / revenue
ROE
-65.9%
FY2025 · return on equity
Total Assets
$8.4M
FY2025
Total Debt
-
FY2025
Equity
$6.0M
FY2025
ROA
-47.3%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$2.5M-1.6% YoYNet Income HistoryProfit after all expenses and taxes-$4.0M+4.2% YoYGross Profit HistoryRevenue minus cost of goods sold$1.0MCost of Revenue HistoryDirect costs of producing goods and services sold$0Operating Income HistoryProfit from core business operations before interest and taxes-$4.2M+6.9% YoYSG&A Expense HistorySelling, general, and administrative expenses$3.4M-4.1% YoYR&D Expense HistoryResearch and development spending$3.3M-5.9% YoYInterest Expense HistoryCost of borrowing and debt obligations$249.9K-29.8% YoYIncome Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share-$2.57+5.2% YoY